Wastewater and environmental surveillance (WES) – the analysis of water and environmental samples like sewage to enable early, non-invasive tracking of biological and chemical markers across a population – is a powerful and increasingly common public health tool. When paired with clinical data, it offers a real-time window into community health that can inform faster, more targeted responses to infectious disease. However, its use in carceral settings like jails and prisons remains ethically underexamined.

In a brief analytic essay in the American Journal of Public Health, a team comprised of Boston University and University of Louisville researchers found that carceral WES is neither fully covered by human subjects protections nor fully accountable to traditional public health guidelines, producing a fragmented regulatory landscape in which some safeguards impede informed and effective research while others fail to prevent misuse or harm to incarcerated individuals and surrounding communities.

Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in MSCI Global Small Cap Indexes compiled by Morgan Stanley Capital International (MSCI). The change will take effect as of the close of August 31, 2026.